Vimarsana
Biggest News Aggregation in the World

Page 8 - Teva Pharms News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Teva Pharms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Teva Pharms Today - Breaking & Trending Today

Creative Claiming Strategies - Patent - United States - Vimarsana News

Creative Claiming Strategies - Patent - United States

Innovator companies in the biopharmaceutical space are looking to their patent counsel for creative patent claiming strategies to protect their assets.

Source: mondaq.com
Protecting Both Intellectual Property And Progress - Patent - Vimarsana News

Protecting Both Intellectual Property And Progress - Patent

The goal of most biopharmaceutical companies is to develop an FDA-approved treatment. But FDA approval takes time, money, and often the use of patented materials for developing, testing, and screening new drugs...

Source: mondaq.com
Novartis Pharmaceuticals Corp. v. Accord Healthcare, Inc. (Fed. Cir. 2022) | McDonnell Boehnen Hulbert & Berghoff LLP - Vimarsana News

Novartis Pharmaceuticals Corp. v. Accord Healthcare, Inc. (Fed. Cir. 2022) | McDonnell Boehnen Hulbert & Berghoff LLP

The Federal Circuit recently granted a panel rehearing and vacated a panel decision between these parties decided earlier this year (see Novartis Pharmaceuticals Corp. v. Accord...

 - Vimarsana News

Case Name: Adapt Pharma Operations Ltd. v. Teva Pharms. USA, Inc., Case No. 2020-2106, 25 F.4th 1354 (Fed. Cir. Feb. 10, 2022) (Circuit Judges Newman, Prost, and Stoll presiding;...

GlaxoSmithKline LLC v. Teva Pharms. USA, Inc. | Robins Kaplan LLP - Vimarsana News

GlaxoSmithKline LLC v. Teva Pharms. USA, Inc. | Robins Kaplan LLP

Case Name: GlaxoSmithKline LLC v. Teva Pharms. USA, Inc., 25 F.4th 949 (Fed. Cir. 2022) (Circuit Judges Moore, Newman, Dyk, Prost, O’Malley, Reyna, Taranto, Chen, Hughes, and Stoll...